Assessment of gabapentin misuse using prescription drug monitoring program data-Reference-Cited by-同舟云学术

Assessment of gabapentin misuse using prescription drug monitoring program data

Published:2021-03-09 Issue:4 Volume:42 Page:454-459
ISSN:0889-7077
Container-title:Substance Abuse
language:en
Short-container-title:Substance Abuse

Author:

Zhang Yifan¹^ORCID,Castracane Alexandria R.²,Winstanley Erin L.³⁴^ORCID

Affiliation:

1. School of Pharmacy, West Virginia University, Morgantown, West Virginia, USA

2. Kroger Pharmacy, Decatur, Illinois, USA

3. Department of Behavioral Medicine and Psychiatry, School of Medicine and Rockefeller Neuroscience Institute, West Virginia University, Morgantown, West Virginia, USA

4. Department of Neuroscience, School of Medicine, West Virginia University, Morgantown, West Virginia, USA

Publisher

Informa UK Limited

Subject

Psychiatry and Mental health,Medicine (miscellaneous)

Link

https://www.tandfonline.com/doi/pdf/10.1080/08897077.2021.1891602

Reference47 articles.

1. Gabapentin: A New Agent for the Management of Epilepsy

2. The Impact of Gabapentin Administration on Brain GABA and Glutamate Concentrations: A 7T 1H-MRS Study

3. Parke-Davis Pharmaceutical. Neurontin. Published 1998. https://www.accessdata.fda.gov/drugsatfda_docs/nda/98/020235S011.pdf.

4. Gabapentin Approvals, Off-Label Use, and Lessons for Postmarketing Evaluation Efforts

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Strategies for Abuse Liability Assessment of New Chemical Entities;A Comprehensive Guide to Toxicology in Nonclinical Drug Development;2024

2. Design and Production of DNA-Based Electrochemical and Biological Biosensors for the Detection and Measurement of Gabapentin Medication in Clinical Specimens;Journal of The Electrochemical Society;2022-07-01